Heart failure in adults with congenital heart disease - What is different about drug treatment?
|
|
- Roland Allen
- 5 years ago
- Views:
Transcription
1 Heart failure in adults with congenital heart disease - What is different about drug treatment? G. P. Diller Adult Congenital Heart Disease Program, Royal Brompton Hospital, London, GB Division of Adult Congenital and Valvular Heart Disease, Department of Cardiology, University of Münster, Germany
2 No conflict of interest to declare 2
3 Definition of heart failure A state in which the heart fails to maintain an adequate circulation for the needs of the body despite a satisfactory filling pressure Paul Wood, 1950 A clinical syndrome caused by an abnormality of the heart and recognised by a characteristic pattern of haemodynamic, renal, neural and hormonal responses PooleWilson, 1985 I. Symptoms of heart failure (at rest or during exercise) and II. objective evidence of cardiac dysfunction (rest) and (in cases where the diagnosis is in doubt) III. response to treatment directed towards heart failure ESC Task Force 2005
4 Heart failure symptoms common in ACHD 22% dtga, 32 % cctga, 40% Fontan HF symptoms
5 Exercise Intolerance Diller, G.-P. et al. Circulation 2005
6 Bolger, A. P. et al. Circulation 2002 Bolger, A. P, EHJ 2003 Neurohormonal Activation 47 patients with chronic HF due to ischaemic or DCM vs 83 ACHD patients
7 Immune Activation Bolger, A. P. et al. Circulation 2002 Sharma et al. Am J Card 2003
8 Ohuchi et al Circulation 2002 Neurohormonal- / Immune Activation / Autonomic dysfunction (Fontan patients) Younger patients ANP/BNP in the APC vs TCPC group CANA and lower HR variability related to the number of previous surgeries
9 Underlying heart disease Impaired exercise capacity Signs and symptoms of heart failure Neurohormonal and immune activation Bolger et al. Eur Heart J. 2003
10 Reduced life expectancy TOF UVH Syst RV Nieminen HP, Circulation 2001
11 Heart failure common cause of death Nieminen HP et al JACC 2007
12 Treatment challeging Jessup M, NEJM 2003
13 Physiology and Anatomy different from acquired HF Extrapolating results to ACHD difficult RV LV? Ellipsoid Anderson, Becker 1980
14 Studies of HF medication in ACHD disappointing 1. ACE-I Randomized study n=18; Fontan pts. 10 wks. FU No change in pvo 2 oder CI Kouatli AA, Circulation 1997
15 Studies of HF medication in ACHD disappointing 1. ACE-I n=63, 10 ACE-I Therapy
16 Studies of HF medication in ACHD disappointing 1. ACE-I n=14, 6 mths. AJC 2001
17 Studies of HF medication in ACHD disappointing 1. ACE-I n=9, dtga, Enalapril 12 mths. Ped Cardiol 2002
18 Studies of HF medication in ACHD disappointing 1. ACE-I Abstract 2031: ACE Inhibitors for Potential PRevention of the Deleterious Effects of Pulmonary Regurgitation In Adults with TEtralogy of Fallot Repair - The APPROPRIATE Study - A Randomised, Double-Blinded, Placebo-Controlled Trial in Adults with Congenital Heart Disease Sonya V Babu-Narayan; Anselm Uebing; Periklis A Davlouros; Michael Kemp; Simon Davidson; Omer Goktekin; Stephanie Bayne; Philip J Kilner; Wei Li; Michael A Gatzoulis Royal Brompton Hosp, London, United Kingdom Background: Angiotensin Converting Enzyme (ACE) inhibitors have been regarded as useful in aortic regurgitation, but their effectiveness with volume loading of the right ventricle (RV) due to pulmonary regurgitation (PR), a cause of late morbidity and mortality after repair of tetralogy of Fallot (ToF), remains unknown. We therefore undertook what we believe to be the first randomised, double-blinded, placebo-controlled drug trial in adults with congenital heart disease, on the effect of ACE inhibition in patients with repaired ToF and PR. Methods and Results: Sixty-Four adults with repaired TOF and at least moderate PR were randomly assigned to six months ramipril 10 mg or six months placebo in a double-blinded fashion. New York Heart Association (NYHA) class, maximal VO 2, pulmonary regurgitant fraction (PRF), RV and left ventricular (LV) end-systolic volume index (ESVi) and ejection fraction (EF) by cardiovascular magnetic resonance, and RV and LV long axis function on M-Mode echocardiography, were similar in both groups at baseline. Treated patients demonstrated significant improvement in RV and LV amplitude of long axis shortening (16.2 ± 4.8 versus 17.8 ± 4.8; P = and 14.6 ± 4.3 versus 16.2 ± 3.6 mm; P = 0.008), RV and LV stroke volume index ( 74.1 ± 18.3 versus 78.9 ± 21.3; P = 0.06, 45.8 ± 7.3 versus 9.8 ± 9.7 mls/m 2 ; P = 0.02) and a trend to improvement in global RVEF (53.5 ± 8.3 versus 55.3 ± 7.0 %; P = 0.08). No significant difference was demonstrated in NYHA class (1.19 ± 0.4 versus 1.19 ± 0.4; P = 1.0), VO 2 max (25.7 ± 5.9 versus 25.3 ± 7.0 ml/min/kg; P = 0.58), PRF (39.2 ± 10.4 versus 37.8 ± 10.9 %; P = 0.17), RVESVi or LVESVi (66.6 ± 25.3 versus 66.9 ± 30.3 ml/m 2 ; P =0.9, 25.1 ± 9.2 versus 24.9 ± 9.0 ml/m 2 ; P = 0.9). Similar increases in atrial and brain natriuretic peptide (ANP;BNP) levels were seen in both groups between baseline and follow up (ANP: +4.2 ± 5.4 placebo versus +2.3 ± 4.6 treatment; P = 0.15 pmol/l, BNP: +3.7 ± 5.8 placebo versus +7.6 ± 8.8 treatment pmol/l; P = 0.25). Conclusions: Six months of ramipril treatment did not reduce pulmonary regurgitant fraction or decrease ventricular size. Increases in RV and LV long axis function, stroke volumes and RV ejection fraction are potentially beneficial but the changes were modest and their clinical significance remains open.
19 Studies of HF medication in ACHD disappointing 2. ARBs n=7, cross over, EF und Exercise capacity AJC 2001
20 Studies of HF medication in ACHD disappointing 2. ARBs 21 Mustard 8 cctga Multicenter, rand., double-blind, cross-over study 29 pts. (21 dtga, 8 cctga) 15 wk. Losartan 2x50 mg/die
21 Studies of HF medication in ACHD 2. ARBs
22 Studies of HF medication in ACHD 2. ARBs Van der Bom T, ESC 2012
23 Studies of HF medication in ACHD 3. b-blockers NYHA, RVED-area retrospective, 60 pts. (31 b-blockers) Doughan A, AJC 2007
24 Studies of HF medication in ACHD 3. b-blockers 8 pt. SRV 12 mths. Carvedilol Target dose 25 mg/die (reached 62% of pts.) RVEDV, RVESV & RVEF Giardini A, IJC 2006
25 Determinants of peak oxygen consumption Univariate analysis r - value P - value Peak pulse 0.49 < NYHA class < Cyanosis < Pulmonary hypertens < Gender < Age < Age at surgery < %FEV < %FVC 0.22 < SV function PV function Peak systolic BP Diller, G.-P. et al. Circulation 2005
26 Chronotropic Incompetence common in ACHD Diller, G.-P. et al. IJC 2008
27 Treating CI not necessarily beneficial Figure 1. Heart rate and peak oxygen consumption (peak VO2) with pre-existing pacemaker (PM) settings and with after active reprogramming. One patient (marked with an asterisk) developed atrial tachycardia at the test with pre-existing pacemaker settings.
28 Treating CI not necessarily beneficial Figure 3. Comparison between systemic (right) ventricular total isovolumic time (t-ivt), total filling time (t-ft) and aortic velocity time integral (VTI) at 3 different heart rates (HR). Non-parametric Wilcoxon tests (paired samples) were used to compare data.
29 Treating CI not necessarily beneficial ECG Phono FT Circulation Nov 7;102(19 Suppl 3):III Failure of stroke volume augmentation during exercise and dobutamine stress is unrelated to load-independent indexes of right ventricular performance after the Mustard operation. Derrick GP, Narang I, White PA, Kelleher A, Bush A, Penny DJ, Redington AN. HR 68 bpm HR 110 bpm HR 140 bpm t-ivt 17.1 s/min t-ivt 27.0 s/min t-ivt 28.0 s/min t-ft 24.8 s/min t-ft 15.6 s/min t-ft 13.9 s/min VTI 10.7 cm VTI 5.3 cm VTI 4.2 cm
30 Symptoms Hypothyroidism, Anaemia, Lung function, PHT Life style Extracardiac problems Haemodynamic problems Arrhythmias Surgey / Interventions Asynchrony, SCD EP? weak evidence Medical therapy CRT/CRT-D Transplantation Assist devices Supportive care
31 Conclusion Heart failure is a common problem in adults with CHD Associated with considerable morbidity and mortality Extrapolating from data in patients with (acquired) left heart disease is not straightforward Commonly a preload problem / diastolic dysfunction Assess indication for surgery/intervention for residual haemodynamic lesions Assess pts. as part of multidisciplinary team ACHD cardiologists/ EP/ Surgeons
32 Thank you.
Tetralogy of Fallot Latest data in risk stratification and replacement of pulmonic valve
Tetralogy of Fallot Latest data in risk stratification and replacement of pulmonic valve Alexandra A Frogoudaki Adult Congenital Heart Clinic Second Cardiology Department ATTIKON University Hospital No
More informationManagement of Heart Failure in Adult with Congenital Heart Disease
Management of Heart Failure in Adult with Congenital Heart Disease Ahmed Krimly Interventional and ACHD consultant King Faisal Cardiac Center National Guard Jeddah Background 0.4% of adults have some form
More informationEvaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death
Evaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death Presenters: Sabrina Phillips, MD FACC FASE Director, Adult Congenital Heart Disease Services The University of Oklahoma
More informationANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS IN HEART FAILURE FROM CHD
ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS IN HEART FAILURE FROM CHD Karen Stout, MD FACC Professor, Medicine/Pediatrics University of Washington Seattle, WA USA No disclosures Case 35 year old man with
More informationACHD & Heart Disease and Pregnancy: Guidelines and Cases Michael A. Gatzoulis
ACHD & Heart Disease and Pregnancy: Guidelines and Cases Michael A. Gatzoulis Adult Congenital Heart Centre & National Centre for Pulmonary Hypertension Royal Brompton Hospital/National Heart & Lung Institute,
More informationThe Failing Systemic Right Ventricle European Society of Cardiology 2012
The Failing Systemic Right Ventricle European Society of Cardiology 2012 I have nothing to disclose. Is the right ventricle an inherently weaker ventricle? Functionally single ventricle TGA (after atrial
More informationPulmonary Valve Replacement
Indications/Timing and Type of Interventions: Pulmonary Valve Replacement Lars Sondergaard, MD, DMSc Professor of Cardiology Rigshospitalet Copenhagen, Denmark Case 15 years old girl with tetralogy of
More informationCandice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada
PVR Following Repair of TOF Now? When? Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada Late Complications after TOF repair Repair will be necessary
More informationThe right heart: the Cinderella of heart failure
The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart
More informationArrhythmias in Adult Congenital Heart Disease
Arrhythmias in Adult Congenital Heart Disease NAAMA s 24 th International Medical Convention Beirut, Lebanon June 26 July 2, 2010 Naser Ammash, MD Mayo School of Medicine Rochester, Minnesota CP1212391-1
More informationCASE REPORT. Case Report
CASE REPORT Regular Treatment Strategy with a Large Amount of for Heart Failure Improves Biventricular Systolic Failure in a Patient with Repaired Tetralogy of Fallot Katsura Soma, 1 MD, Atsushi Yao, 2
More informationRisk Stratification in ACHD
Adult Congenital Heart Centre & Centre for Pulmonary Hypertension Royal Brompton Hospital Risk Stratification in ACHD Konstantinos Dimopoulos, MD, MSc, PhD, FESC Consultant Cardiologist RISK: noun Risk
More informationDebate in CHD - When Should We
Debate in CHD - When Should We Replace Pulmonary Valve? Lee, Jae Young Dept. of Pediatrics, Seoul Saint Mary s Hospital The Catholic University of Korea 14 yr/m, TOF repair (1yr) FC I PR Fraction - 48
More informationManagement of complex CHD in adults
Management of complex CHD in adults Victor Tsang Society of Thoracic Surgeons of Thailand 2016 The impact of infant cardiac surgery Over 90 % of infants born with CHD will reach adulthood By 2010, adults
More informationPregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia
Pregnancy, Heart Disease and Imaging Sangeeta Shah, MD, FASE, FACC Associate Professor, Ochsner Clinical School of Medicine Advanced CV Imaging and Adult Congenital Heart Disease New Orleans, LA Hemodynamics
More informationPulmonary Hypertension: Follow-up in adolescence and adults
Pulmonary Hypertension: Follow-up in adolescence and adults Helmut Baumgartner Westfälische Wilhelms-Universität Münster Adult Congenital and Valvular Heart Disease Center University of Muenster Germany
More informationEisenmenger Syndrome: A Call for Action
Cardiology Update, Davos 2013 Eisenmenger Syndrome: A Call for Action Adult Congenital Heart Centre & National Centre for Pulmonary Hypertension Royal Brompton Hospital/National Heart & Lung Institute,
More informationResearch Presentation June 23, Nimish Muni Resident Internal Medicine
Research Presentation June 23, 2009 Nimish Muni Resident Internal Medicine Research Question In adult patients with repaired Tetralogy of Fallot, how does Echocardiography compare to MRI in evaluating
More informationLatest Results from Clinical Trials (MAESTRO)
EuroGUCH 2018 & 11 th Advanced Symposium on ACHD Munster April 2018 Latest Results from Clinical Trials (MAESTRO) Michael A Gatzoulis Adult Congenital Heart Centre & National Centre for Pulmonary Hypertension
More informationEffects of heart rate reduction with ivabradine on left ventricular remodeling and function:
Systolic Heart failure treatment with the If inhibitor ivabradine Trial Effects of heart rate reduction with ivabradine on left ventricular remodeling and function: results of the SHIFT echocardiography
More informationEffects of heart rate reduction with ivabradine on left ventricular remodeling and function:
Systolic Heart failure treatment with the If inhibitor ivabradine Trial Effects of heart rate reduction with ivabradine on left ventricular remodeling and function: results of the SHIFT echocardiography
More informationHeart Failure A Disease for the Internist?
Heart Failure A Disease for the Internist? Dr Chris Davidson Sussex Cardiac Centre BRIGHTON UK Hot Topics in Heart Failure Drug treatments Valsartan / neprilysin inhib Investigations BNP and others Devices
More informationNatural History and Echo Evaluation of Aortic Stenosis
Natural History and Echo Evaluation of Aortic Stenosis Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM AORTIC STENOSIS First valvular disease
More informationBi-Ventricular pacing after the most recent studies
Seminars of the Hellenic Working Groups February 18th-20 20,, 2010, Thessaloniki, Greece Bi-Ventricular pacing after the most recent studies Maurizio Lunati MD Director EP Lab & Unit Cardiology Dpt. Niguarda
More informationCardiac MRI in ACHD What We. ACHD Patients
Cardiac MRI in ACHD What We Have Learned to Apply to ACHD Patients Faris Al Mousily, MBChB, FAAC, FACC Consultant, Pediatric Cardiology, KFSH&RC/Jeddah Adjunct Faculty, Division of Pediatric Cardiology
More informationImaging of Repaired Tetralogy of Fallot in Adults
SURGICAL MORPHOLOGY and IMAGING of CONGENITAL HEART DISEASE WORKSHOP 22 nd SEPTEMBER, 2016 Imaging of Repaired Tetralogy of Fallot in Adults Tan Ju-Le MBBS, MRCP, FAMS, FACC, FESC Director, Senior Consultant
More informationHeart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output
Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover
More informationHeart Failure. GP Update Refresher 18 th January 2018
GP Update Refresher 18 th January 2018 Heart Failure Dr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK President of British
More informationRisk Stratification for Sudden Death in ACHD
Risk Stratification for Sudden Death in ACHD Paul Khairy, MD, PhD Scientific Director, Adult Congenital Center Professor of Medicine and Research Chair, University of Montreal Living with the Risk of Sudden
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Cardiovascular magnetic resonance for timing pulmonary valve replacement E.Valsangiacomo Buechel University Children s Hospital Zurich Outline Introduction Pulmonary
More informationMini Forum for Pediatric Cardiac Disease in Young Adulthood
Mini Forum for Pediatric Cardiac Disease in Young Adulthood Acta Cardiol Sin 2015;31:478 484 doi: 10.6515/ACS20150210A Assessing Late Cardiopulmonary Function in Patients with Repaired Tetralogy of Fallot
More informationTake-home Messages from Recent Heart Failure Trials: Heart Rate as a Target
Take-home Messages from Recent Heart Failure Trials: Heart Rate as a Target JEFFREY S. BORER, M.D. Professor and Chairman, Department of Medicine and Chief, Division of Cardiovascular Medicine; Director,
More informationΜαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling
More informationWhen to implant an ICD in systemic right ventricle?
When to implant an ICD in systemic right ventricle? Département de rythmologie et de stimulation cardiaque Nicolas Combes n.combes@clinique-pasteur.com Pôle de cardiologie pédiatrique et congénitale Risk
More informationDiagnosis is it really Heart Failure?
ESC Congress Munich - 25-29 August 2012 Heart Failure with Preserved Ejection Fraction From Bench to Bedside Diagnosis is it really Heart Failure? Prof. Burkert Pieske Department of Cardiology Med.University
More informationCardiac rehabilitation: a beneficial effect in CHD?
Cardiac rehabilitation: a beneficial effect in CHD? An Van Berendoncks Department of Cardiology Antwerp University Hospital Outline Why exercise training in CHD? Risk and benefits? Feasibility? Why should
More informationNew in Heart Failure SGK autumn session 2012
New in Heart Failure SGK autumn session 2012 Roger Hullin Cardiology Department of Internal Medicine Centre Universitaire Hospitaler Vaudois University of Lausanne ESC Heart Failure Guidelines 2012 Classes
More informationRVOTO adult and post-op
Right ventricular outflow tract obstruction in the adult: native and post-op Helmut Baumgartner Westfälische Wilhelms-Universität Münster Adult Congenital and Valvular Heart Disease Center University of
More informationInterventions in Adult Congenital Heart Disease: Role of CV Imaging. Associate Professor. ACHD mortality. Pillutla. Am Heart J 2009;158:874-9
Interventions in Adult Congenital Heart Disease: Role of CV Imaging Sangeeta Shah MD, FACC, FASE Associate Professor ACHD mortality Pillutla. Am Heart J 2009;158:874-9 Adult Congenital Heart Disease Heterogenity
More informationInnovation therapy in Heart Failure
Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure
More informationS. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences
S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences No financial disclosures Aorta Congenital aortic stenosis/insufficiency
More informationMRI (AND CT) FOR REPAIRED TETRALOGY OF FALLOT
MRI (AND CT) FOR REPAIRED TETRALOGY OF FALLOT Linda B Haramati MD, MS Departments of Radiology and Medicine Bronx, New York OUTLINE Pathogenesis Variants Initial surgical treatments Basic MR protocols
More informationTherapeutic Targets and Interventions
Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium
More informationNT-proBNP: Evidence-based application in primary care
NT-proBNP: Evidence-based application in primary care Associate Professor Rob Doughty The University of Auckland, Auckland City Hospital, Auckland Heart Group NT-proBNP: Evidence in Primary Care The problem
More informationESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response
More informationHeart Failure Medical and Surgical Treatment
Heart Failure Medical and Surgical Treatment Daniel S. Yip, M.D. Medical Director, Heart Failure and Transplantation Mayo Clinic Second Annual Lakeland Regional Health Cardiovascular Symposium February
More informationComplex Congenital Heart Disease in Adults
Complex Congenital Heart Disease in Adults Linda B. Haramati, MD Disclosures Complex Congenital Heart Disease in Adults Linda B. Haramati MD, MS Jeffrey M. Levsky MD, PhD Meir Scheinfeld MD, PhD Department
More informationCardiovascular MRI of Adult Congenital Heart Disease
Cardiovascular MRI of Adult Congenital Heart Disease Anil K. Attili, MD Cardiovascular Magnetic Resonance imaging of Adult Congenital Heart Disease Anil Attili, M.D. Assistant Professor of Radiology /Cardiology
More informationImaging in dilated cardiomyopathy : factors associated with a poor outcome
Imaging in dilated cardiomyopathy : factors associated with a poor outcome Johan De Sutter, MD, PhD, FESC AZ Maria Middelares Gent and University Gent - Belgium Dilated cardiomyopathy Cardiomyopathy with
More informationDON T FORGET TO OPTIMISE DEVICE PROGRAMMING
CRT:NON-RESPONDERS OR NON-PROGRESSORS? DON T FORGET TO OPTIMISE DEVICE PROGRAMMING Prof. ALİ OTO,MD,FESC,FACC,FHRS Chairman,Department of Cardiology Hacettepe University Faculty of Medicine,Ankara Causes
More informationPulmonary Regurgitation after TOF Repair. How to Assess and Options of Management? Worakan Promphan, MD.FSCAI.
Pulmonary Regurgitation after TOF Repair. How to Assess and Options of Management? Worakan Promphan, MD.FSCAI. Queen Sirikit National Institute of Child Health (QSNICH) Bangkok, Thailand How to Assess?
More informationSurgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital
Surgical Management of TOF in Adults Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital Tetralogy of Fallot (TOF) in Adults Most common cyanotic congenital heart
More informationEchocardiography in Adult Congenital Heart Disease
Echocardiography in Adult Congenital Heart Disease Michael Vogel Kinderherz-Praxis München CHD missed in childhood Subsequent lesions after repaired CHD Follow-up of cyanotic heart disease CHD missed in
More informationHeart Failure with preserved ejection fraction (HFpEF)
Heart Failure with preserved ejection fraction (HFpEF) Dr. Pierpaolo Pellicori Hull York Medical School Kingston-upon-Hull United Kingdom Conflict of interest: none Heart failure is a contemporary problem
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACHD. See Adult congenital heart disease (ACHD) Adult congenital heart disease (ACHD), 503 512 across life span prevalence of, 504 506
More informationAldosterone Antagonism in Heart Failure: Now for all Patients?
Aldosterone Antagonism in Heart Failure: Now for all Patients? Inder Anand, MD, FRCP, D Phil (Oxon.) Professor of Medicine, University of Minnesota, Director Heart Failure Program, VA Medical Center 111C
More informationDiagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham
Diagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Chronic heart failure
More informationThe Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?
The Who, How and When of Advanced Heart Failure Therapies 9 th Annual Dartmouth Conference on Advances in Heart Failure Therapies Dartmouth-Hitchcock Medical Center Lebanon, NH May 20, 2013 Joseph G. Rogers,
More informationReport on the Expert Group Meeting of Paediatric Heart Failure, London 29 November 2010
Report on the Expert Group Meeting of Paediatric Heart Failure, London 29 November Clinical trials in Paediatric Heart Failure List of participants: Michael Burch, Hugo Devlieger, Angeles Garcia, Daphne
More informationA teenager with tetralogy of fallot becomes a soccer player
ISSN 1507-6164 DOI: 10.12659/AJCR.889440 Received: 2013.06.06 Accepted: 2013.07.10 Published: 2013.09.23 A teenager with tetralogy of fallot becomes a soccer player Authors Contribution: Study Design A
More informationRestrictive Right Ventricular Physiology
Journal of the American College of Cardiology Vol. 50, No. 15, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.06.042
More informationADULT CONGENITAL HEART DISEASE AN UPDATE FOR CARDIOLOGISTS AND PRIMARY CARE PHYSICIANS
ADULT CONGENITAL HEART DISEASE AN UPDATE FOR CARDIOLOGISTS AND PRIMARY CARE PHYSICIANS V.S. Mahadevan, MD, F.R.C.P. Director, Structural and Adult congenital Interventional Cardiology Program William W
More informationInstitute of Cardiology Warsaw, Poland
Mateusz Śpiewak, Elżbieta K. Biernacka, Łukasz A. Małek, Jolanta Miśko, Joanna Petryka, Mirosław Kowalski, Barbara Miłosz, Magdalena Żabicka, Piotr Hoffman, Witold Rużyłło Institute of Cardiology Warsaw,
More informationMechanisms of heart failure with normal EF Arterial stiffness and ventricular-arterial coupling. What is the pathophysiology at presentation?
Mechanisms of heart failure with normal EF Arterial stiffness and ventricular-arterial coupling What is the pathophysiology at presentation? Ventricular-arterial coupling elastance Central arterial pressure
More informationESC Guidelines for the Diagnosis and Treatment of Chronic Heart Failure
ESC Guidelines for the Diagnosis and Treatment of Chronic Heart Failure - 2005 Karl Swedberg Professor of Medicine Department of Medicine Sahlgrenska University Hospital/Östra Göteborg University Göteborg
More informationHeart Failure from a GP perspective
Heart Failure from a GP perspective Jane Gilmour, Alison Wright Clinical Nurse Specialists for Heart Failure The Heart failure Team Dr Ganesan Kumar- Consultant Cardiologist Dr D Maras- Staff Grade Cardiology
More informationThe right ventricle in chronic heart failure
The right ventricle in chronic heart failure ESC 2012 Christian Opitz, Berlin There are no conflicts of interest relevant to this presentation Percent of Population Prevalence of Heart Failure by Age and
More informationWhich Cyanotic Patient Needs Anticoagulation?
Which Cyanotic Patient Needs Anticoagulation? Erwin Oechslin, MD, FRCPC, FESC Director, Adult Congenital Heart Disease Program The Bitove Family Professor of ACHD Professor of Medicine, U of T Peter Munk
More informationCopyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Normal Cardiac Anatomy
Mosby,, an affiliate of Elsevier Normal Cardiac Anatomy Impaired cardiac pumping Results in vasoconstriction & fluid retention Characterized by ventricular dysfunction, reduced exercise tolerance, diminished
More informationVentricular-Pulmonary Vascular Coupling after the Total Cavopulmonary Anastomosis (Fontan)
Ventricular-Pulmonary Vascular Coupling after the Total Cavopulmonary Anastomosis (Fontan) 6th International Neonatal & Childhood Pulmonary Vascular Disease Conference Fontan Physiology Single ventricular
More informationVentricular Interactions in the Normal and Failing Heart
Ventricular Interactions in the Normal and Failing Heart Congenital Cardiac Anesthesia Society 2015 Pressure-volume relations Matched Left ventricle to low hydraulic impedance Maximal stroke work limited
More informationHow to Approach the Patient with CRT and Recurrent Heart Failure
How to Approach the Patient with CRT and Recurrent Heart Failure Byron K. Lee MD Associate Professor of Medicine Electrophysiology and Arrhythmia Section UCSF Update in Electrocardiography and Arrhythmias
More informationChecklist for Treating Heart Failure. Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute
Checklist for Treating Heart Failure Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute Novartis Disclosure Heart Failure (HF) a complex clinical syndrome that arises secondary to abnormalities
More informationClinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!
Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!! Abha'Khandelwal,'MD,'MS' 'Stanford'University'School'of'Medicine'
More informationCOMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE?
COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE? Aurora S. Gamponia, MD, FPPS, FPCC, FPSE OBJECTIVES Identify complex congenital heart disease at high risk or too late for intervention
More informationImpedance Cardiography (ICG) Method, Technology and Validity
Method, Technology and Validity Hemodynamic Basics Cardiovascular System Cardiac Output (CO) Mean arterial pressure (MAP) Variable resistance (SVR) Aortic valve Left ventricle Elastic arteries / Aorta
More informationPREGNANCY IN PATIENTS WITH A SYSTEMIC RV
PREGNANCY IN PATIENTS WITH A SYSTEMIC RV Carole A. Warnes MD, FRCP Professor of Medicine, Mayo Clinic No disclosures 2013 MFMER slide-1 PREGNANCY : SYSTEMIC RV D - transposition after atrial switch procedure
More informationPulmonary valve: Imaging assessment
Pulmonary valve: Imaging assessment Fraisse Royal Brompton and Harefield Hospital London, U.K. Consultant and Proctor for medtronic Potential consequences of pulmonary valve Dysfunction RV obstruction
More informationEcho assessment of the failing heart
Echo assessment of the failing heart Mark K. Friedberg, MD The Labatt Family Heart Center The Hospital for Sick Children Toronto, Ontario, Canada Cardiac function- definitions Cardiovascular function:
More informationHFpEF: How to optimise management
HFpEF: How to optimise management Burkert Pieske M.D. Berlin, Germany Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, and Department of Internal
More informationPercutaneous pulmonary valve replacement after different duration of free pulmonary regurgitation in a porcine model: effects on the right ventricle
Percutaneous pulmonary valve replacement after different duration of free pulmonary regurgitation in a porcine model: effects on the right ventricle Mads Ersboll a, Niels Vejlstrup a, Jens Christian Nilsson
More informationHeart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre
Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:
More informationOnline Appendix (JACC )
Beta blockers in Heart Failure Collaborative Group Online Appendix (JACC013117-0413) Heart rate, heart rhythm and prognostic effect of beta-blockers in heart failure: individual-patient data meta-analysis
More informationAtrial dysfunction and chronotropic incompetence
Pathophysiology of heart failure with preserved ejection fraction Atrial dysfunction and chronotropic incompetence Vojtech Melenovsky IKEM, Prague, Czech Republic DECLARATION OF CONFLICT OF INTEREST :
More informationBeyond ACE-inhibitors for Heart Failure. Jacob Townsend, MD NCVH Birmingham 2015
Beyond ACE-inhibitors for Heart Failure Jacob Townsend, MD NCVH Birmingham 2015 % Decrease in Mortality Current Therapy HFrEF 0% Angiotensin receptor blocker ACE inhibitor Beta blocker Mineralocorticoid
More informationEjection Fraction in Patients With Chronic Heart Failure. Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction
Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction Keith Miller MD Diastolic Heart Failure Risk Factors Common Risk Factors Aging Female gender Obesity Hypertension Diabetes mellitus
More informationRef 1. Ref 2. Ref 3. Ref 4. See graph
Ref 1 Ref 2 Ref 3 1. Ages 6-23 y/o 2. Significant LVM differences by gender 3. For males 95 th percentiles: a. LVM/BSA = 103 b. LVM/height = 100 4. For females 95 th percentiles: a. LVM/BSA = 84 b. LVM/height
More informationCurrent Indications for Cardiac MRI: What You See is What You Get?
Current Indications for Cardiac MRI: What You See is What You Get? Javier Ganame, MD, PhD, FASE No disclosures Cardiology Update, Niagara, Sept 24th, 2016 The Ideal Diagnostic Technique Easy to apply Accurate
More informationA pulmonary vascular resistance of 8 Woods units per meter squared defines operablity in congenital heart disease
A pulmonary vascular resistance of 8 Woods units per meter squared defines operablity in congenital heart disease RMF Berger Beatrix Children s Hospital University Medical Center Groningen The Netherlands
More informationCLINICAL RESEARCH. Aims
European Heart Journal (2012) 33, 2434 2441 doi:10.1093/eurheartj/ehs200 CLINICAL RESEARCH Impact of reduction in right ventricular pressure and/or volume overload by percutaneous pulmonary valve implantation
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Is there a mortality risk associated with aspirin use in heart failure? Results from a large community based cohort Margaret Bermingham, Mary-Kate Shanahan, Saki Miwa,
More informationHypertensive heart disease and failure
Hypertensive heart disease and failure Prof. Dr. Alan Fraser Cardiff University The heart in hypertension Pathophysiology of LV adaptation Regional development of hypertrophy Stress testing - inducible
More informationNew NICE Heart Failure Guidelines What do they mean for primary and secondary care, and patients?
New NICE Heart Failure Guidelines 2018 - What do they mean for primary and secondary care, and patients? Prof Ahmet Fuat PhD FRCGP FRCP PG Dip (Cardiology) GP & GPSI Cardiology Darlington Professor of
More informationEvaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension
ESC Congress 2011.No 85975 Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension Second Department of Internal
More informationPulmonary Valve Replacement
Pulmonary Valve Replacement Christian Kreutzer MD Hospital Nacional Alejandro Posadas Hospital Universitario Austral (No disclosures) Scope of the problem. CHD with PS or PA require a RVOT procedure. Tetralogy
More informationPulmonary vasodilators in Fontan Patients
Pulmonary vasodilators in Fontan Patients Maurice Beghetti Pediatric Cardiology University Children s Hospital HUG and CHUV Pulmonary Hypertension Program HUG Centre Universitaire Romand de Cardiologie
More informationHeart Failure Update John Coyle, M.D.
Heart Failure Update 2011 John Coyle, M.D. Causes of Heart Failure Anderson,B.Am Heart J 1993;126:632-40 It It is now well-established that at least one-half of the patients presenting with symptoms and
More informationEchocardiographic and Doppler Assessment of Cardiac Functions in Patients of Non-Insulin Dependent Diabetes Mellitus
ORIGINAL ARTICLE JIACM 2002; 3(2): 164-8 Echocardiographic and Doppler Assessment of Cardiac Functions in Patients of Non-Insulin Dependent Diabetes Mellitus Rajesh Rajput*, Jagdish**, SB Siwach***, A
More informationTetralogy of Fallot is a common form of cyanotic heart
Predicting Outcome of Pulmonary Valve Replacement in Adult Tetralogy of Fallot Patients Ivo R. Henkens, MD, Alexander van Straten, MD, Martin J. Schalij, MD, PhD, Mark G. Hazekamp, MD, PhD, Albert de Roos,
More informationA patient with decompensated HF
A patient with decompensated HF Professor Michel KOMAJDA University Pierre & Marie Curie Pitie Salpetriere Hospital Department of Cardiology Paris (France) Declaration Of Interest 2010 Speaker : Servier,
More information